Veracyte officer plans $586K Rule 144 sale

Veracyte, Inc. (VCYT) received a Rule 144 notice that Philip Febbo plans to sell up to 13,110 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Rhea-AI Filing Summary

Veracyte, Inc. (VCYT) received a Rule 144 notice that Philip Febbo plans to sell up to 13,110 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ market. The shares were acquired from Veracyte upon vesting of restricted stock units during the period from March 2, 2026 through September 2, 2026.

Key Figures

Shares proposed to be sold: 13,110 shares Aggregate value of shares: $585,623.70 Acquisition date cited: March 2, 2026 +1 more

4 metrics

Shares proposed to be sold 13,110 shares Common stock covered by the Rule 144 notice

Aggregate value of shares $585,623.70 Aggregate value listed for the 13,110 shares of common stock

Acquisition date cited March 2, 2026 Date shown in the securities-to-be-sold section for RSU acquisition

RSU vesting period March 2, 2026 to September 2, 2026 Period during which the RSUs vested and were acquired

Key Terms

Rule 144, restricted stock units, common stock, NASDAQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

common stock financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

NASDAQ market

"| 09/04/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for VCYT disclose about planned share sales?

The Form 144 notice states that 13,110 shares of Veracyte (VCYT) common stock may be sold under Rule 144. The planned sales are to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Who is selling Veracyte (VCYT) shares in this Form 144 filing?

The notice is filed for the account of Philip Febbo, identified as an officer. The sales will be executed through Morgan Stanley Smith Barney LLC’s Executive Financial Services group.

How many Veracyte (VCYT) shares are covered by this Rule 144 notice?

The filing covers a potential sale of 13,110 shares of Veracyte common stock. This figure appears both in the securities information and in the section describing securities to be sold.

What is the approximate value of the Veracyte (VCYT) shares in this Form 144?

The securities information section lists an aggregate value of $585,623.70 for the 13,110 shares of Veracyte common stock proposed to be sold under Rule 144.

How and when were the Veracyte (VCYT) shares in this Form 144 acquired?

The shares were acquired from Veracyte upon the vesting of restricted stock units. The remarks state that vesting occurred during the period from March 2, 2026 through September 2, 2026.

On which market will the Veracyte (VCYT) shares be sold under this Form 144?

The Form 144 indicates that the 13,110 shares of Veracyte common stock are to be sold on the NASDAQ market through Morgan Stanley Smith Barney LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:29 PM EDT Accepted by SEC EDGAR 09/04/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001649245
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERACYTE, INC.
SEC File Number	001-36156
Address of Issuer	6000 Shoreline Court, Suite 300 South San Francisco CALIFORNIA 94080
Phone	6502436300
Name of Person for Whose Account the Securities are To Be Sold	PHILLIP FEBBO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13110	585623.70	80390731	09/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock Units	Issuer			13110	03/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 3/2/2026 through 9/2/2026.
Date of Notice	09/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Philip Febbo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)